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Abstract Metabolomics data obtained from (human)
nutritional intervention studies can have a rather complex
structure that depends on the underlying experimental
design. In this paper we discuss the complex structure in
data caused by a cross-over designed experiment. In such a
design, each subject in the study population acts as his or
her own control and makes the data paired. For a single
univariate response a paired t-test or repeated measures
ANOVA can be used to test the differences between the
paired observations. The same principle holds for multi-
variate data. In the current paper we compare a method that
exploits the paired data structure in cross-over multivariate
data (multilevel PLSDA) with a method that is often used
by default but that ignores the paired structure (OPLSDA).
The results from both methods have been evaluated in a
small simulated example as well as in a genuine data set
from a cross-over designed nutritional metabolomics study.
It is shown that exploiting the paired data structure
underlying the cross-over design considerably improves the
power and the interpretability of the multivariate solution.
Furthermore, the multilevel approach provides comple-
mentary information about (I) the diversity and abundance
of the treatment effects within the different (subsets of)
subjects across the study population, and (II) the intrinsic
differences between these study subjects.
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1 Introduction
Metabolomics data from human studies are often charac-
terised by large variations between the subjects. This is
different from most animal studies where metabolic vari-
ation between the test animals is usually less abundant. A
global overview with respect to nutritional metabolomics is
provided by Rezzi et al. (2007).
The large variation between human subjects can give
rise to two problems in the analysis. The ﬁrst is that small
and subtle treatment effects (e.g. dietary responses) can
easily be overlooked, especially when the effect is smaller
than the intrinsic variation between the subjects. The sec-
ond problem is that the response and the impact of the
treatment effect may differ between the subjects. This
implies that an average treatment effect may not be the
most relevant in studies where subsets of subjects respond
differently upon a dietary intervention. An often used
solution in clinical or nutritional studies is the use of a
cross-over design. In a cross-over study all subjects acts as
their own control. As a result, multivariate data obtained
from a cross-over designed experiment has a paired data
structure.
When a cross-over design is used in the study, the
treatment effect for each subject can be separated from the
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founded sources of variation, both can be analyzed sepa-
rately. The analysis of paired data is usually performed
with a paired t-test and repeated measures ANOVA in case
of univariate responses. Depending on the ratio between
the effect size and the variation between the subjects, a
paired t-test is advantageous over a normal t-test due to its
increased statistical power. Figure 1 illustrates the princi-
ple of both t-tests by means of 5 subjects that have been
measured in the control period (A) and in the treatment
period (B). From these subjects a univariate response was
acquired. The columns A and B in Table 1 show the
measurement responses collected in the control period and
the treatment period respectively. The values in column D
represent the differences between A and B, whereas M
represents the mean of A and B.
In Fig. 1 the difference between the unpaired analysis
and the paired analysis is demonstrated. In Fig. 1b, the
paired data structure is accentuated by the connection lines
between the two measurements. Without considering the
paired structure, a normal unpaired t-test does not show a
statistically signiﬁcant difference between A and B. The
average of B minus the average of A equals 3 ± 4.61
(P = 0.172).
When the paired data structure is used in a paired t-test,
then the difference D between control group A and treat-
ment group B becomes statistically signiﬁcant. In that case
the difference is 3 ± 1.57 (P = 0.009).
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Fig. 1 Basic principles of a unpaired and b paired data analysis of
measurement responses from 5 subjects in the control period (class 0)
and in the treatment period (class 1) respectively. In (a)n o
consideration is given to the paired data structure. The effect of the
treatment is represented by the dotted line. As shown by the
projections of the observations on the dotted line, the discriminant
model is not able to separate the intervention classes well. On the
Y-axis the overlapping distributions of the two intervention classes
are projected. If (b) a paired analysis is used instead (illustrated by the
lines connecting the 5 data pairs), the data is separated into a mean
(black circles) and a difference (d) per subject. The differences (net
treatment effect) are projected on the Y-axis per subject, and are all
different from 0. The dotted circle represents two similar mean
values. (Color ﬁgure online)
Table 1 Univariate example with paired data
Subject A B D M
1 2 5 3 3.5
2 4 9 5 6.5
3 6 7 1 6.5
4 8 11 3 9.5
5 10 13 3 11.5
The measurement responses of 5 subjects are shown that were col-
lected in the control period (A) and treatment period (B). Columns D
and M represent the difference and the mean of A and B for each
subject
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123By using the paired structure of the data from cross-over
studies, statistically signiﬁcance can be obtained for much
smaller treatment effects. However, besides the advantage
in power, it is also possible to examine the difference in
treatment effect within the subjects in a much easier way
than without the separation of the different sources of
variation. At the same time the differences between the
subjects can be studied without being confounded with the
treatment effect. In the univariate example the treatment
effect is not similar for all subjects. This variation simu-
lates the intrinsic differences between subjects.
Nowadays, cross-over designs are also used in combi-
nation with ‘omics’ techniques, resulting in paired multi-
variate data sets (Bertram et al. 2006; Pohjanen et al. 2007;
van Velzen et al. 2008). Time series experiments with
different subjects have the same paired data structure
(Jansen et al. 2005; Rantalainen et al. 2008), and the
analysis of such data sets can also be improved when
exploiting the design underlying the study. However, in the
analysis of these multivariate paired data, the study design
is not always considered. Instead of using a multivariate
extension of the paired t-test, in general other methods are
being applied that particularly focus upon the mean effects
over all subjects.
In this paper we will discuss the multivariate extension of
the paired t-test, which is recently introduced as multilevel
data analysis (van Velzen et al. 2008). We will demonstrate
the additional beneﬁt of multilevel data analysis in the
analysis of multivariate paired (cross-over) data in com-
parison with a method that does not explicitly consider the
cross-over design (OPLSDA). We will examine the differ-
ences in a tutorial style by using a small simulation study as
well as a genuine cross-over designed (nutritional) study.
Both these studies are analysed with OPLSDA and multi-
level PLSDA. The results obtained from both analyses are
evaluated, compared and discussed. To introduce this
methodological evaluation, we will ﬁrst provide a brief
description of OPLSDA and multilevel PLSDA, and in
which way these methods deal with paired data.
2 Theory
2.1 OPLSDA
OPLSDA was introduced as an improvement of the PLSDA
method to discriminate two or more groups (classes) using
multivariate data (Bylesjo et al. 2006; Trygg and Wold
2002). In OPLSDA a regression model is calculated
between the multivariate data and a response variable that
only contains class information. The advantage of OPLSDA
compared to PLSDA is that a single component is used as a
predictor for the class, while the other components describe
the variation orthogonal to the ﬁrst predictive component.
Wiklund et al. (2008) used the terms between treatment
variation to describe the average effect of treatment and
within treatment variation to describe the systematic
remainder variation which is not related to the treatment.
The treatment effect is considered equal for all subjects
although the magnitude is allowed to be different for each
subject. Treatment effects that differ from the average
treatmenteffectare referred toaswithintreatmentvariation.
The predictive OPLSDA component actually describes
the direction of the difference (the treatment effect)
between the average of class A and the average of class B
according the representation given in Fig. 1a (dotted line).
Then all samples are projected on this component to esti-
mate the predictive scores. Although a group-average
effect is observed in this example, the projections on the
line clearly shows that the classes are not well separated.
Furthermore, in OPLSDA only a single predictive com-
ponent is calculated (in case of a two-class problem). When
the treatment effect manifest differently among the subjects
in the test population, this will not be observed by the
OPLSDA method.
2.2 Multilevel PLSDA
Multilevel PLSDA is another discrimination method that
was recently introduced to develop classiﬁcations models
of multivariate data from cross-over designed studies, i.e.
an experimental setup in which each subject underwent a
control measurement and a treatment (in a random order)
(van Velzen et al. 2008). Multilevel PLSDA can be con-
sidered as a multivariate extension of a paired t-test.
Multilevel data analysis can only be used when the data has
a multilevel structure, whereas OPLSDA can be used for
any discrimination problem.
In a multilevel PLSDA model, the variation between
subjects (within treatment variation in OPLSDA) and the
variation within subjects (total variation due to the treat-
ment) are separated. The within subject variation in mul-
tilevel PLSDA is not considered the same for each subject
as compared to the between treatment variation in
OPLSDA. The between subject variation in multilevel data
analysis is performed on the average of the two observa-
tions (balck circles in Fig. 1b), whereas the within subject
variation is performed on the net differences between the
paired observations (d in Fig. 1b).
The initial step in multilevel PLSDA is to separate the
between subject variation from the within subject variation.
First, the observations in the control (A) and the treatment
(B) periods are concatenated:
A
B
  
: The between subject
variation has structure
M
M
  
; where M ¼ 1
2 A þ B ½  : The
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123within subject variation is calculated according:
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: Its structure is  D
D
  
; where D ¼
B   A ½  : In this two-class problem this just comes down to
an analysis on the differences between the data obtained in
the two classes. The rank of the within subject variation
matrix is usually larger than one, because the effect of the
treatment is generally different between the subjects. In
that case, more than a single component is needed to
provide a good description of the within subject variation
in the study population.
Because of its structure, analysis of the within subject
variation can be done with several multivariate methods
e.g. PCA, PLSDA or even OPLSDA. The within subject
variation contains both variation that is equal for all sub-
jects as well as variation that is different between subjects.
When MLPLSDA is used to describe the within subject
variation, the focus is on the similarity in the treatment
effect between the subjects. Therefore the ﬁrst MLPLSDA
component primarily describes the main, corresponding
effect, whereas the latter components particularly reﬂect
the differences in treatment effect among the subjects.
When MLPCA is used, the focus is simply on the major
variation in the within treatment variation.
2.2.1 Why does this work
Consider the data measured in a study where I (i = 1…I)
individuals are measured at D (d = 1…D) occasions. Then
each measurement xdi can be explained partly by a grand
mean l, the group effect ad, while the remainder is an
unexplained residual.
xdi ¼ l þ ad þ edi ð1Þ
Here the group effect estimate ad equals the mean of all xdi
averaged over all I individuals. In a one-way ANOVA
approach the Mean Square of xdi would be related to the
Mean Square of edi leading to an F-value with D - 1 and
D(I - 1) degrees of freedom. However in this approach we
ignore that besides the ﬁxed effect due to the classes there
is also a random effect due to the individual. For a new
individual we cannot predict the effect in advance, but we
can model it when the data for the new individual is
obtained (Sokal and Rohlf 1998). Thus in the case of a
cross-over design where the same individuals are measured
at D occasions Eq. 1 can be extended with the random
individual effect
xdi ¼ l þ ad þ bi þ fdi ð2Þ
bi is estimated as the mean of all D values for individual i.
Note that ad does not change when the individual effect is
included in the model since edi ¼ bi þ fdi; thus the random
effect is a part of the variation that was ﬁrst collected in the
residual edi. This means that the new residual fdi is smaller,
and thus the estimated effect of MS ad over MS fdi will be
larger than the previous ANOVA estimate. Thus the paired
data analysis will have a higher power.
Note that xdi   bi ¼ l þ ad þ fdi; i.e. the original data
minus the mean over all treatments equals exactly
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tains the means bi for all individuals. For a three class
problem this would lead to
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X data is then related to a dummy Y-matrix
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A; where 1 and 0 represent vectors of I ones
and zeros respectively. Note however that a PLSDA model
with more than 2 classes is not straightforward (Indahl
et al. 2007; Barker and Rayens 2003; Nocairi et al. 2005).
The ANOVA model described here suits the study
design described in the simulation study as well as in the
real data example. For different type of studies other
ANOVA models apply, but the extension to multivariate
multilevel classiﬁcation models is similar to the situation
discussed above.
2.3 Data pretreatment
In multilevel analysis all sources of variation (in this case
the between individual variation as well as the between
individual variation) are of interest. However, the infor-
mation that can be obtained from these data may be dif-
ferent. Therefore the type of scaling used can be adjusted
for each subset of variation. This approach of scaling after
variation splitting is considered as an important beneﬁt of
the multilevel approach, as the preferred scaling technique
can explicitly be adapted to the part of the data that is
examined and the data analysis technique used.
2.4 Score plots
In our previous work on the assessment of PLSDA vali-
dation (Westerhuis et al. 2008a) we concluded that score
plots should not be used for assessing and interpreting the
class separation since the PLSDA model may highly overﬁt
the data. This problem is especially related to multivariate
or high dimensional data where the number of variables is
much higher than the number of samples. A possible
solution to this problem is the use of cross-validated scores
in a score plot (Wiklund et al. 2008). However, a problem
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123with this approach is that the cross-validated scores are all
based on different loadings. For that reason the scores
cannot be drawn in a similar ﬁgure. Only if the differences
between the various loadings obtained from the different
models in the cross-validation are small, then a composite
ﬁgure with cross-validated scores may be useful. In the
current work we will use double cross-validated scores
(Smit et al. 2007; Westerhuis et al. 2008a) to evaluate the
difference between the OPLSDA model and the multilevel
PLSDA model. We will address the aspects of class sep-
aration and the score distribution in relation to the different
sources of variation.
3 Analysis of simulated data
3.1 A small simulated example
The properties of paired data and the consecutive data
analysis will be explained in a brief example using a small,
simulated data. Let’s consider the measurement responses
of three variables A, B and C (e.g. metabolite concentra-
tions) in 10 subjects, which were collected in the control
period as well as in the treatment period (Table 2).
In this example variable B increases ?2 for all subjects
after the treatment. Variable A increased ?1 for the odd
subjects (males) and ?3 for the even subjects (females).
Variable C did not change. The effect of the treatment is
clearly visible for variables A and B (see columns DA and
DB) and not for C (see column DC). A small fraction of
random normally distributed noise was added to the data
before analysis.
3.2 OPLSDA analysis of simulated example
To perform OPLSDA analysis a y vector was constituted
which include the class information for each subject. This
column vector contains the class label value -1 for the
control group, and the class label value ?1 for the treat-
ment group. An OPLSDA model (with 3 components)
between the original data ABC ½  and the y vector was
calculated. It should be noted that the estimated scores
changed upon the number of OPLSDA components cal-
culated. These changes, however, were small and did not
inﬂuence the conclusions derived from this simulated
experiment.
In Fig. 2 the predictive scores tP versus the orthogonal
scores tO are illustrated. The score plot shows that the
control group (red squares) is not well separated from the
treatment group (blue circles). Although a clear and sys-
tematic difference was simulated across the intervention
periods, the OPLSDA model was not able to detect this
treatment effect. The problem is that methods that do not
Table 2 Simulated measurement responses of three variables A, B
and C in 10 subjects collected in the control period and the treatment
period
Occasion Subject A B C DA DB DC MA MB MC
Control period 1 20 10 20 -1 -2 0 20.5 11 20
21 8 1 2 1 7 -3 -2 0 19.5 13 17
31 6 1 5 1 4 -1 -2 0 16.5 16 14
41 4 1 6 1 1 -3 -2 0 15.5 17 11
51 0 2 8 -1 -2 0 10.5 3 8
69 3 5 -3 -2 0 10.5 4 5
77 7 2 -1 -2 0 7.5 8 2
87 7 8 -3 -2 0 8.5 8 8
93 9 1 4 -1 -2 0 3.5 10 14
10 2 9 17 -3 -2 0 3.5 10 17
Treatment period 1 21 12 20 ?1 ?2 0 20.5 11 20
22 1 1 4 1 7 ?3 ?2 0 19.5 13 17
31 7 1 7 1 4 ?1 ?2 0 16.5 16 14
41 7 1 8 1 1 ?3 ?2 0 15.5 17 11
51 1 4 8 ?1 ?2 0 10.5 3 8
61 2 5 5 ?3 ?2 0 10.5 4 5
78 9 2 ?1 ?2 0 7.5 8 2
81 0 9 8 ?3 ?2 0 8.5 8 8
9 4 11 14 ?1 ?2 0 3.5 10 14
10 5 11 17 ?3 ?2 0 3.5 10 17
The difference (D) and mean (M) for each subject and for each
variable are given
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Fig. 2 Double cross validated OPLSDA score plot of simulated data.
The predicted scores tP versus the orthogonal scores tO1 of the control
group (red squares) and the treatment group (blue circles) are shown.
The black dots highlights the male subjects in the study population.
No class separation between the control and treatment groups as well
as between the males and the females could be observed. (Color ﬁgure
online)
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123use the paired data structure, only focus on the difference
between the class means and the ranges of the classes.
When the between class difference is small compared to
the range of the observed responses, this difference drowns
in the total variation and will not be detected. The loadings
of the OPLSDA model 0:73 0:72 0:01 ½  indicate that par-
ticularly the ﬁrst two variables are important for the pre-
dictive component. Nevertheless, the obtained model does
not allow a good discrimination between the two classes.
Another limitation that appears when ignoring the paired
data structure is that no emphasis can be given to the var-
iation in effect between the subjects. This is illustrated in
the simulated example (Table 2) where the male subjects
(odd sample numbers) have a relative small increase in
variable A as compared to the females (even sample num-
bers). Methods that do not use the paired data structure only
focuses on the difference between the average value of the
controls and the treated samples and do not consider a
variation in the treatment effect. The score distribution of
the males and the females in Fig. 2 clearly demonstrates
that the OPLSDA model is not able to discriminate between
these systematic, gender-related, response differences.
Note that in Fig. 2, the effect of the treatment is clearly
visible on the predictive score (tP) however it drowns in the
large variation caused by the different individuals. Thus
OPLSDA estimates the loadings well, but the effect is not
statistically signiﬁcant
3.3 Multilevel PLSDA analysis of the within subject
variation of the simulated data
The multilevel approach takes the paired data structure into
account. The total variation in the data is divided into
between subject variation and within subject variation. The
within subject variation exclusively describes the net dif-
ferences in each of the measured variables for each subject,
i.e.  1; 3; 1; 3;... ½  for variable A,  2; 2; 2; ½  2;... 
for variable B and 0; 0; 0; 0;... ½  for variable C. The large
variation between the subjects is completely ignored when
the within subject variation is analyzed. Furthermore, the
gender-related difference in effect that manifest in variable
A remain clearly present in the within variation.
In the estimation of the between subject variation, the
mean observations are used, i.e. 20:5; 19:5; 16:5; 15:5;... ½  for
variable A, 11; 13; 16; 17;... ½  for variable B and
20; 17; 14; 11;... ½  for variable C. After variation splitting,
this source of variation can be analyzed without being
confounded with the treatment-related variation.
In Fig. 3 the multilevel PLSDA scores tW1 and tW2 of
the within subject variation are shown. A clear separation
is observed between the control group and the treatment
group. Since multilevel PLSDA particularly focuses on the
within subject variation that is similar among the subjects,
the ﬁrst component mainly describes the difference
between the classes. The second component on the other
hand describes the within subject variation that is different
between the subjects. We therefore observe a notable
separation between the males and females in the test
population.
3.4 Multilevel PCA analysis of the between subject
variation of the simulated data
Besides the within subject variation, also the between
subject variation was examined. Note that the between
subject data only consists of 10 subjects, and that variation
due to the treatment has been removed. To investigate the
main variation between the subjects, a multilevel PCA
analysis was performed. Figure 4 shows the score plot of
the between subject variation for the ﬁrst two principal
components. Three groups of subjects appear, i.e., (I)
subjects 1–4, (II) subjects 5–8 and (III) subjects 9 and 10.
These groups are primarily associated with the absolute
abundances of the variables.
4 Analysis of experimental data
4.1 Study design
The intervention study has a double-blind, placebo-con-
trolled cross-over design with a single, oral intervention of
black tea solids. The black tea solids contained 800 mg
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Fig. 3 The multilevel PLSDA scores (tW1, tW2) of the within subject
variation in simulated data on the ﬁrst two components. The red
squares represents the subjects in the control group. The blue circles
represents the same subjects after the treatment. The males (black
dots) experienced a smaller increase in variable A relative to the
females. (Color ﬁgure online)
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123polyphenols based on gallic acid equivalents and were
administered as non-transparent capsules. In total, 20 male
subjects participated in the study (18–40 years of age and
Body Mass Index between 19 and 29 kg/m
2). Urine sam-
ples were collected (and weighted) from all subjects over a
time span of 48 h after the intervention.
4.2 Sample pre-preparation
To investigate the main effects in the data, pooled 48 h
urines were prepared. This was done by adding aliquots of
the urines together in exactly the same mass-ratio as the
collected fractions. Then, to 450 ll of each pooled urine
sample 200 ll phosphate buffer solution (0.6 M Na2HPO4/
NaH2PO4, pH 6.5) and 50 ll deuterium oxide (D2O) was
added. The phosphate buffer solution contained
0.05 mg ml
-1 3-(trimethylsilyl)propionic acid-d4 sodium
salt (TSP) as an internal standard. After homogenization
and centrifugation 650 ll of the clear supernatant was
transferred into a 5-mm NMR tube.
4.3 Data acquisition and data pre-processing
600 MHz
1H NMR spectra were acquired at 300 K on a
Bruker Avance 600 MHz NMR spectrometer. The data
were collected into 64 K points (128 scans) using a spectral
width of 9000 Hz, an acquisition time of 3 s and a relax-
ation delay of 3 s (with suppression of the water signal).
The Fourier transformed NMR spectra were manually
phase- and baseline corrected, calibrated and normalized
against the methyl resonance of TSP at d 0.0 ppm. Finally,
the intensities of the NMR signals were expressed in molar
equivalents by multiplying the TSP normalized spectra
with the total volumes of the 48 h urines. The resulting
NMR spectra were then subdivided in discrete regions
(‘buckets’) of equal width (d 0.00225 ppm). As bucketing
could not completely compensate for line broadening
effects and positional shifts (due to differences in pH, ion
strength, etc.), also Correlation Optimized Warping (COW)
(Skov and Bro 2008; Wu et al. 2006) was applied on the
bucketed data. A detailed description of the study and the
analytical procedure was recently reported by the authors
(van Velzen et al. 2009).
4.4 Data analysis
Based on our previous ﬁndings with the same dataset, we
only consider the aromatic region of the NMR spectrum
(d 6–9 ppm) in the data analysis. Calculations involving
data pre-treatment (bucketing, normalization, volume cor-
rection), multilevel PLSDA, OPLSDA, double cross vali-
dation (2CV), permutation testing, and Discriminant Q
2
(DQ
2) (Westerhuis et al. 2008b) estimations were per-
formed using Matlab (version 2009a, The MathWorks,
USA) with in-house written Matlab routines. These rou-
tines (together with a tutorial) are available at http://www.
bdagroup.nl/.
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Fig. 4 Score plot of multilevel PCA model representing the between
subject variation on the ﬁrst two principal components. Three main
clusters could be identiﬁed. The separation of the score clusters is
related to the absolute abundances of the variables
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Fig. 5 Double cross-validated OPLSDA scores representing the
autoscaled urinary NMR spectra of 20 male subjects. The observa-
tions obtained in the control period (red squares) and the treatment
period (blue circles) have the tendency to form two separate classes.
Note that there is only one predictive score and one orthogonal score.
The predictive score indicates the separation between the two
intervention groups. Different from Wiklund et al. (2008) the cross
validated scores give different values for tP as well as for tO1
compared to the non-crossvalidated scores. (Color ﬁgure online)
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1234.5 OPLSDA analysis of the experimental data
Before analysis, autoscaling of the data was used to
improve the weight of the smaller intensities. The (double)
cross-validated scores in Fig. 5 show that the OPLSDA
model was able to provide a reasonable class estimation of
the autoscaled data. The DQ
2 of the classiﬁcation model
was 0.25 (based on the average result of 20 2CV runs),
which was higher than all 2500 DQ
2 values obtained from
models from permuted data (Lindgren et al. 1996; West-
erhuis et al. 2008a). Even though the distribution of cross-
validated scores of the subjects in the control group is
different from the treatment group, still we can observe a
large dispersion across the intervention groups in the
direction of predictive score component (tP).
4.6 Multilevel analysis of the experimental data
In the ﬁrst step of the multilevel analysis the variation is
separated into the between individuals contribution and the
within individuals contribution (the treatment effect). The
latter is autoscaled before analysis give extra weight to the
smaller intensities. The between individual variation is not
scaled because we were interested in the larger effects in
this data.
When the paired data structure is used in the multilevel
PLSDA analysis of the experimental data, a systematic
difference revealed between the control group and the
treatment group. This is demonstrated in Fig. 6a, d where
the double cross-validated scores reﬂects the within subject
variation in the 48 h urine samples of all subjects between
the intervention periods. The DQ
2 of the multilevel model
was 0.54 (the average result of 20 2CV runs), which was
statistically signiﬁcant in a permutation test. Again 2500
permutations were performed. The DQ
2 was also higher
than the DQ
2 obtained in the previously described
OPLSDA analysis.
In Fig. 6b the main treatment effect was observed along
the ﬁrst component. Some individuals with high scores on
the ﬁrst component are indicated with colored markers and
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Fig. 6 Multilevel PLSDA double cross-validated scores which
represent the urinary NMR spectra of 20 subjects after black tea
intake. The (a and d) scores on the ﬁrst two components (t1,t 2)
reﬂects the within subject variation in the control period (red squares)
and the treatment period (blue circles). Two different treatment
effects could be identiﬁed. The (b) ﬁrst effect along the ﬁrst
component point towards (c) increasing hippuric acids levels and
increasing 1,3-dihydroxyphenyl-2-O-sulphate levels. The (e) second
effect along the second component is basically described by (f)
1,3-dihydroxyphenyl-2-O-sulphate, whereas the increase of hippuric
acid is less pronounced. (Color ﬁgure online)
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123their corresponding spectra are shown in Fig. 6c. The ﬁrst
component is largely inﬂuenced by elevated levels of
hippuric acid (Fig. 6c), 1,3-dihydroxyphenyl-2-O-sulphate
and some other aromatic signals. These observations match
our previous ﬁndings on the same data. However, this main
effect was not equal for all subjects. As shown in Fig. 6e,
another subset of individuals responds differently upon the
black tea intervention. In this subpopulation are individuals
that score low on the ﬁrst component as their increase of
the urinary hippuric acid levels was less pronounced.
However this subpopulation score much higher on the
second multilevel PLS component which is dominated by
the 1,3-dihydroxyphenyl-2-O-sulphate levels (Fig. 6f). The
current observations lead to the conclusion that not all
subjects respond equally to the treatment, and demonstrate
that a single component for such a classiﬁcation model is
not sufﬁcient to assess the different treatment effects within
a study population.
Besides the within variation, also the between subject
variation was explored. The combination of both (multi-
level) analyses will then allow a comprehensive interpre-
tation of all major variation sources in the data. Similarly to
the simulated example, a multilevel PCA analysis was
appropriate to assess the main intrinsic variations between
the subjects (on mean-centred data). As shown in Fig. 7a,
the scores of 4 subjects on the second principal component
tB2 appear to be different from the other subjects. Whereas
the ﬁrst principal component (Fig. 7b, black proﬁle) is a
generic representation of all NMR signal intensities, dif-
ferent variations among the NMR resonances were
observed on the second principal component (Fig. 7b, red
proﬁle). The loadings show that the variation between the
subjects particularly depends on the ratio between the
NMR signals of hippuric acid (d 7.78 ppm, d; d 7.59 ppm, t
and d 7.50 ppm, t) and the NMR signals of an unknown
aromatic compound, U (d 7.17 ppm, s; d 7.24 ppm, s and d
7.31 ppm, s). This unknown compound was observed in a
spectral region were several other resonance patterns of
aromatic amino acids, (conjugated) polyphenolic acids,
(indole) alkaloids etc. come together. For now this com-
plicates a straightforward identiﬁcation of component U.
Four subjects appear to have a higher signal ratio between
U and hippuric acid then the other subjects in the study
population.
5 Conclusion
In this paper we have shown that when the paired data
structure of metabolomics data obtained from a cross-over
designed experiment, is taken into account during the
multivariate data analysis, the power and the interpret-
ability of the results greatly improves. Furthermore the
multilevel approach provides information about the
-15 -10 -5 0 5 10 15
-4
-3
-2
-1
0
1
2
3
4
5
6 AB
7 7.2 7.4 7.6 7.8
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
1H chemical shift (ppm)
PC1
Hippuric acid
U
tB1
t
B
2
PC2
Fig. 7 Variation between the mean-centered 24 h urinary NMR
proﬁles of 20 subjects as represented by (a) the tB1 and tB2 scores in
the multilevel PCA score plot. The (b) associated loadings reﬂect the
intensity depended variation along the spectral axis (PC1) and
variations between hippuric acid and component U (PC2). The ratio
between hippuric acid and U is different in four subjects (red dots).
(Color ﬁgure online)
Multivariate paired data analysis 127
123diversity and abundance of the treatment effects across the
study population. Finally, the multilevel analysis allows
investigation of the between subject variation which is
completely separated from the within subject variation.
However, often this paired data structure is ignored during
the analysis and default methods that do not consider the
paired data structure are used to analyze the data, leading to
suboptimal results. In this paper we have discussed the
difference between the paired analysis and the non-paired
analysis approaches and used a simulated example as well
as a real experiment in which a human test panel was given
black tea solids. In the latter study we observed two subsets
in the human test population that responded differently
upon the intake of black tea solids. These subsets show
differences in urinary excretion of hippuric acid and
1,3-dihydroxyphenyl-2-O-sulphate. We also observed
intrinsic differences between the subjects. These variations
are mainly described by the relative levels (or molar ratio)
of hippuric acid and an unknown aromatic component (U).
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